Affinia Therapeutics has received FDA orphan drug designation for AFTX-201, a treatment in development for BAG3-associated DCM.

The funds will help Crystalys progress its clinical-stage development efforts and commercialisation plans for its gout drug, dotinurad.

GSK's newly approved ROS1-positive NSCLC drug, Jideytro will now enter a lung cancer niche dominated by Pfizer’s Lorbrena.

Evogene and ELEO have entered into a scientific collaboration aimed at discovering and developing new oral small-molecule inhibitors targeting the PCSK9 pathway for hyperlipidemia and cardiovascular ...

Cellares and Papillon Therapeutics have entered into a partnership to automate the manufacturing of PPL-001, an investigational therapy developed by the latter for FA, a rare inherited ...

Kyowa Kirin EMEA, a subsidiary of Kyowa Kirin, has received approval from the EC to expand the use of Crysvita for treating XLH in infants aged one month to one year across the EU and European ...

If introduced, the 100% tariffs would apply to all generic drugs imported to the US, which make up 90% of the nation’s prescriptions.

Samsung Biologics has been on a steep upward growth trajectory since receiving its first licence to produce biologic drug substances in 2015.

BMS enhances its AI computing power with NVIDIA's DGX SuperPOD as big pharma race to stay competitive within the shifting global landscape.

Despite a lacklustre start to the year, Novartis seems to have overcome its financial slump, reporting operating profits in Q2 that exceeded analyst expectations. The Swiss drugma ...

In a lawsuit filed in the US, Novo alleged that Lilly’s campaign was designed to mislead consumers on “comparative efficacy” of drug brands.

The EMA’s CHMP has granted PRIME designation to AbelZeta Pharma’s C-CAR168, an autologous anti-CD20/BCMA CAR-T therapy.